Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

45.75

45.75

45.75

45.75

45.75

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

4,171.66

3,549.79

3,161.55

2,818.66

2,347.29

Loan funds

Secured loans

2.50

2.50

2.50

2.50

2.50

Unsecured loans

-

-

-

-

-

Total

4,219.91

3,598.04

3,209.80

2,866.91

2,395.54

Uses of funds

Fixed assets

Gross block

1,025.06

972.27

978.90

1,050.27

1,035.22

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

301.44

259.56

229.65

181.14

140.92

Net block

723.62

712.71

749.25

869.13

894.30

Capital work-in-progress

7.64

0.40

7.93

1.15

2.76

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

4,179.85

3,515.67

3,243.55

3,030.23

2,368.84

Less : current liabilities & provisions

691.20

630.74

790.93

1,033.60

870.36

Total net current assets

3,488.65

2,884.93

2,452.62

1,996.63

1,498.48

Miscellaneous expenses not written

-

-

-

-

-

Total

4,219.91

3,598.04

3,209.80

2,866.91

2,395.54

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

364.73

533.83

437.83

338.14

254.98

Number of equity sharesoutstanding (Lacs)

457.48

457.48

457.48

457.48

457.48